UBS Reiterates Buy Rating on Abbott Labs (ABT), Highlights Buying Opportunity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Make sure you own this high-quality MedTech stock: RBC
October 17, 2025 4:00 PM EDTRBC Capital Markets reiterated its Outperform rating on one well-known MedTech stock in a note this week, calling it a high-quality company and saying it would be buyers following what it described as a quarter marked by transient headwinds.
The firm said Abbott's (NYSE: ABT) underlying business momentum is intact, even as the... More
